Moderna's mRNA vaccine targeting norovirus is entering final testing phases, aiming to reduce hospitalizations and healthcare costs associated with the virus. The vaccine could be available by 2026, pending trial results. Norovirus causes significant illness, particularly among vulnerable populations, leading to around 12,000 hospital admissions annually in the UK.